Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 1;13(1):119-123.
doi: 10.21037/hbsn-23-556. Epub 2024 Jan 12.

The global burden of fatty liver disease: the major impact of China

Tian-Wen Lou #  1   2 , Rui-Xu Yang #  1 , Jian-Gao Fan  1
Affiliations
Editorial

The global burden of fatty liver disease: the major impact of China

Tian-Wen Lou et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Fatty liver disease (FLD); hepatitis B virus (HBV); obesity; prevalence; type 2 diabetes mellitus (T2DM).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-556/coif). The authors report that this study was supported by the National Natural Science Foundation of China (Nos. 82170593, 81900507). The authors have no other conflicts of interest to declare.

Figures

Figure 1
Figure 1
The prevalence of NAFLD in different areas and specific population. (A) Prevalence of NAFLD in Latin America, the Middle East and North Africa, South Asia, South-East Asia, North America, East Asia, and Western Europe. Data source: Younossi et al. (3). (B) Prevalence of NAFLD, NAFL and NASH in the overweight group and the obese group. Data source: Quek et al. (4). (C) Prevalence of NAFLD, NASH and advanced liver fibrosis in T2DM patients. Data source: Younossi et al. (5). NAFLD, non-alcoholic fatty liver disease; NAFL, non-alcoholic fatty liver; NASH, non-alcoholic steatohepatitis; T2DM, type 2 diabetes mellitus.
See this image and copyright information in PMC

Comment on

References

    1. Devarbhavi H, Asrani SK, Arab JP, et al. Global burden of liver disease: 2023 update. J Hepatol 2023;79:516-37. 10.1016/j.jhep.2023.03.017 - DOI - PubMed
    1. Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2022;7:851-61. 10.1016/S2468-1253(22)00165-0 - DOI - PubMed
    1. Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 2023;77:1335-47. 10.1097/HEP.0000000000000004 - DOI - PMC - PubMed
    1. Quek J, Chan KE, Wong ZY, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2023;8:20-30. 10.1016/S2468-1253(22)00317-X - DOI - PubMed
    1. Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J Hepatol 2019;71:793-801. 10.1016/j.jhep.2019.06.021 - DOI - PubMed